Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
Open Access
- 2 July 2012
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 122 (7), 2672-2679
- https://doi.org/10.1172/jci61427
Abstract
Central serous chorioretinopathy (CSCR) is a vision-threatening eye disease with no validated treatment and unknown pathogeny. In CSCR, dilation and leakage of choroid vessels underneath the retina cause subretinal fluid accumulation and retinal detachment. Because glucocorticoids induce and aggravate CSCR and are known to bind to the mineralocorticoid receptor (MR), CSCR may be related to inappropriate MR activation. Our aim was to assess the effect of MR activation on rat choroidal vasculature and translate the results to CSCR patients. Intravitreous injection of the glucocorticoid corticosterone in rat eyes induced choroidal enlargement. Aldosterone, a specific MR activator, elicited the same effect, producing choroid vessel dilation -and leakage. We identified an underlying mechanism of this effect: aldosterone upregulated the endothelial vasodilatory K channel KCa2.3. Its blockade prevented aldosterone-induced thickening. To translate these findings, we treated 2 patients with chronic nonresolved CSCR with oral eplerenone, a specific MR antagonist, for 5 weeks, and observed impressive and rapid resolution of retinal detachment and choroidal vasodilation as well as improved visual acuity. The benefit was maintained 5 months after eplerenone withdrawal. Our results identify MR signaling as a pathway controlling choroidal vascular bed relaxation and provide a pathogenic link with human CSCR, which suggests that blockade of MR could be used therapeutically to reverse choroid vasculopathy.Keywords
This publication has 37 references indexed in Scilit:
- Mineralocorticoid receptors in vascular function and diseaseMolecular and Cellular Endocrinology, 2012
- Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channelsProceedings of the National Academy of Sciences of the United States of America, 2011
- Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterializationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Role of Epithelial Sodium Channels and Their Regulators in HypertensionPublished by Elsevier BV ,2010
- Nitric Oxide-mediated Dilation of Arterioles to Intraluminal Administration of AldosteroneJournal of Cardiovascular Pharmacology, 2009
- Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence TomographyPLOS ONE, 2009
- Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular PathologyCirculation Research, 2009
- Surface Expression of Epithelial Na Channel Protein in Rat KidneyThe Journal of general physiology, 2008
- Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityNature Medicine, 2007
- The Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological BiologyNuclear Receptor Signaling, 2007